Safety concern and missing-information matrix
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
“
Mitigation set
RMP Matrix
StatusMitigation set
Our craft
Built around real pharmacovigilance practice.
Service Detail
Document and manage product risks with clear controls.
PharmaRevix authors and updates EU-RMPs, US REMS-supporting content, risk minimization measures, and educational materials for healthcare professionals and patients.
You need an EU-RMP for submission or variation
You need risk minimization materials
You have new safety concerns or signals
You need RMP lifecycle maintenance
Deliverables
Practical outputs your team can use immediately.
RMP or REMS-supporting document package
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Risk minimization measure plan
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Educational material drafts
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Effectiveness evaluation approach
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Lifecycle update tracker
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Workflow
A clear sequence from assessment to handoff.
01
Assess
Review safety profile, signals, and regulatory commitments
02
Plan
Define important identified and potential risks
03
Execute
Design routine and additional risk minimization actions
04
Maintain
Maintain and update the plan as evidence evolves
Proof Package
Every engagement leaves an evidence trail.
The work is designed for real review: authority questions, partner due diligence, quality audits, and internal leadership updates.
EU-RMPREMSSenior-led
EU-RMP and US-REMS authoring and updates
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Risk minimization measure design
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Educational material development
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Effectiveness evaluation and lifecycle updates
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Related Services
Connect this work with adjacent regulatory and safety needs.
Signal Management
PharmaRevix supports signal detection scheduling, validation, prioritization, evaluation, QPPV safety review, and documentation aligned with GVP Module IX.
Explore serviceAggregate Reports Writing
PharmaRevix authors PSUR, PBRER, PADER, ACO, and other periodic safety reports with data coordination, medical assessment, quality review, and final submission support.
Explore serviceQPPV & Local Representative Services
PharmaRevix provides EU and UK QPPV, Deputy QPPV, Local Safety Officer, Contact Person, and local representative support where required by national legislation.
Explore serviceFAQ
Common questions about Risk Management Plans & Mitigation.
Short answers for teams deciding whether this is the right next step.
Ask us anythingRisk management planning documents important risks, risk minimization measures, effectiveness checks, and educational material needs for EU-RMP and US REMS-aligned programs.
Yes. PharmaRevix can scope this as a standalone workstream or connect it with adjacent regulatory affairs, pharmacovigilance, QMS, and submission activities.
The right timing depends on product stage, target markets, and regulatory commitments. PharmaRevix usually starts with a focused review and then sets a workplan with owners, dates, and evidence expectations.
Free 30-minute consultation
Need risk management plans & mitigation support?
Talk with PharmaRevix about scope, timelines, and the cleanest next step for your market or safety obligation.